drugset / Trial / NCT00479570

Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.

NCT00479570

Phase 2 Completed 23 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of up to 200 mg of PF-00446687 on acute sexual arousal and sexual interest in post menopausal females, as well as examining the safety and toleration of the drug.

Timeline

Start
2007-06
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-00446687 Small molecule 200 mg

Indications